Glasses pen newspaper

Carl Zeiss Meditec Share

Investing in Carl Zeiss Meditec AG, is an investment in the future of health. We drive the development of leading-edge technology and make it available for applications in the field of: ophthalmology, neurosurgery, ENT surgery, dental applications and systems for intraoperative radiotherapy in the treatment of breast cancer.

Quotes, Charts & Orderbook

Security Identification Numbers of CZM Shares  
Stock exchange abbrevation AFX
ISIN DE0005313704
Reuters Identification Code (RIC) AFXG.F (exchange floor)
  AFXG.DE (XETRA)
Bloomberg AFX GR

Key Facts at a Glance

  • Basic Data
    ISIN DE0005313704
    Trading segment Prime Standard
    Designated Sponsors HSBC Trinkaus & Burkhardt AG
    Share capital EUR 81,309,610.00
    Admitted capital EUR 81,309,610.00
    Category and nominal value No-par value bearer shares at a nominal value of EUR 1.00 per share
    Stock Markets Deutsche Börse, Frankfurt (XETRA and exchange floor, "Parkett")
    Regional stock exchanges in Berlin, Bremen, Düsseldorf, Hamburg, Munich and Stuttgart
    Capital measures 26-Oct-2006:
    Increase of the share capital of EUR 32,523,844.00 (divided into 32,523,844 no-par value shares) by EUR 48,785,766.00 to EUR 81,309,610.00 (divided into 81,309,610 no-par value shares); capital increase with subscription rights and against contributions in kind and cash contributions.

    10-May-2005:
    Increase of the share capital of EUR 29,682,182.00 against cash contribution by EUR 2,841,662.00 (approx. 10%) to EUR 32,523,844.00; subscription rights of shareholders were excluded.

    01-Feb-2005:
    Increase of the share capital of EUR 28,416,628.00 against contribution in kind by EUR 1,265,553.00 (4.45%) to EUR 29,682,182.00; subscription rights of shareholders were excluded; capital increase was part of the acquisition of the majority holding in IOLTech S.A.

    18-Sep-2003:
    Increase of the share capital of EUR 28,833,300.00 against cash contribution by EUR 2,583,329.00 (10%) to EUR 28,416,629.00; subscription rights of shareholders were excluded.
  • Dividend


  • Key Share Data
      2014/15 2013/14 2012/13 2011/12
    2010/11
    XETRA
    Year-end price (EUR) 1)
    25.00 22.97 22.07 19.92
    13.36
    Year high (EUR) 1) 26.21 25.04 26.88 21.40
    16.44
    Year low (EUR) 1) 19.88 19.75 20.01 13.00
    11.57
    Year average (EUR) 23.18 22.42 23.49 17.41
    14.28
    Daily order book turnover (XETRA) in fiscal year
    EUR 1,332,757 1,043,135 1,343,745 1,128,168
    992,460
    Shares 57,496 46,527 57,205 64,800
    69,500
    Number of shares as of 30. September (million shares) 81,310 81,310 81,310 81,310
    81,310
    Market capitalization as of 30. September (thousand EUR) 2,032,334 1,868,500 1,794,290 1,619,687
    1,086,296
    Earnings per share (EUR) 0.77 0.92 1.13 0.88
    0.82
    Dividend per share (EUR) 0.38 2) 0.40 0.45 0.40
    0.30
    Dividend yield (%) 1) 1.65 1.82 2.25 3.00
    2.68

    1) End of fiscal year: 30. September.
    2) Amounts suggested by the Supervisory Board and the Executive Board of the Carl Zeiss Meditec AG.

     

  • Research Coverage
    Bank/Analyst Phone Current Rating Date Price Target
    Commerzbank
    Daniel Wendorff
    +49-69-13 62 96 48 Hold 01-12-2016 36.00€
    Deutsche Bank
    Gunnar Romer
    +49-69-91 03 19 17 Hold 04-11-2016 32.00€
    Berenberg Bank
    Scott Bardo
    +44-20-32 07 78 69 Buy 19-09-2016 36.00€
    Kepler Cheuvreux
    Oliver Reinberg
    +49-69-47 89 75 26 Buy 14-09-2016 32.00€
    Nord/LB
    Holger Fechner
    +49-5 11-3 61 53 05 Buy 17-08-2016 38.00€
    HSBC
    Richard Latz
    +49-211-9101074 Hold 15-08-2016 36.00€
    DZ Bank                        Sven Kürten +49-69-7 44 79 20 72 Buy 12-08-2016 37.00€
    Independent Research
    Bernhard Weininger
      Hold 17-05-2016 35.00€
    J.P. Morgan Cazenove Anasuya Sarma +44-20-71 34 58 28 Underweight 23-02-2016 27.80€
    LBBW
    Volker Stoll
    +49-7 11-12 77 0568 Hold 07-08-2015 26.00€
    Montega AG
    Dr. Thomas Umlauft
    +49-40-4 11 11 3782
    Hold 22-04-2015 25.00€
    Goldman Sachs
    Veronika Dubajova
    +44-20-7774-1901 Neutral 17-12-2014 25.00€
    Bankhaus Lampe
    Volker Braun
    +49-211-4 95 24 53      
    EQUI.TS GmbH
    Thomas Schießle
    +49-69-954 543 60      

    Please note: Banks and securities firms use different terms for their equity ratings.The information contained in the table is based on publicly available sources that we consider reliable but for which we do not assume any liability.

    In particular, we do not guarantee that the information is complete, accurate or up-to-date. All ratings are based on opinions given by the analysts in question. These do not necessarily reflect the opinion of Carl Zeiss Meditec AG. The assessments may change at any time without prior notice. Exemption from liability applies to Carl Zeiss Meditec AG; it does not refer to the correct rendering of the information based on external sources, in particular public sources.

    Analyst assessments relating to Carl Zeiss Meditec AG shares are only revised each quarter and are therefore not continually updated.

  • Shareholder Structure

    The Carl Zeiss Group holds up to 65 % - see the Chart to get an overview.

For more information: Quotes, Charts & Orderbook

We use cookies on this site. Cookies are small text files that are stored on your computer by websites. Cookies are widely used and help to optimize the pages that you view. By using this site, you agree to their use. more